Format

Send to

Choose Destination
J Rheumatol. 2018 Jan;45(1):40-44. doi: 10.3899/jrheum.170548. Epub 2017 Nov 15.

Routine Use of Quantitative Disease Activity Measurements among US Rheumatologists: Implications for Treat-to-target Management Strategies in Rheumatoid Arthritis.

Author information

1
From University of Alabama at Birmingham, Birmingham, Alabama; Baylor Research Institute, Dallas, Texas, USA. jrcurtis@uabmc.edu.
2
J.R. Curtis, MD, MPH, MS, University of Alabama at Birmingham; L. Chen, MD, PhD, University of Alabama at Birmingham; M.I. Danila, MD, MSc, MSPH, University of Alabama at Birmingham; K.G. Saag, MD, MSc, University of Alabama at Birmingham; K.L. Parham, BA, University of Alabama at Birmingham; J.J. Cush, MD, Baylor Research Institute. jrcurtis@uabmc.edu.
3
From University of Alabama at Birmingham, Birmingham, Alabama; Baylor Research Institute, Dallas, Texas, USA.
4
J.R. Curtis, MD, MPH, MS, University of Alabama at Birmingham; L. Chen, MD, PhD, University of Alabama at Birmingham; M.I. Danila, MD, MSc, MSPH, University of Alabama at Birmingham; K.G. Saag, MD, MSc, University of Alabama at Birmingham; K.L. Parham, BA, University of Alabama at Birmingham; J.J. Cush, MD, Baylor Research Institute.

Abstract

OBJECTIVE:

The aim of our study was to examine why real-world practices and attitudes regarding quantitative measurements of rheumatoid arthritis (RA) have received limited attention.

METHODS:

An e-mail survey asked US rheumatologists to self-report on their use of quantitative measurements (metric).

RESULTS:

Among 439 respondents, metric rheumatologists (58%) were more likely to be in group practice and to use tumor necrosis factor inhibitors. The quantitative tools most commonly used were the Health Assessment Questionnaire (35.5%) and the Routine Assessment of Patient Index Data 3 (27.1%). Reasons for not measuring included time needed and electronic availability. Based on simulated case scenarios, providing more quantitative information increased the likelihood that a patient would change to a different disease-modifying antirheumatic drug or biologic.

CONCLUSION:

Routine use of quantitative measurement for patients in the United States with RA is increasing over time but remains low.

KEYWORDS:

RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SURVEY

PMID:
29142029
PMCID:
PMC5750102
DOI:
10.3899/jrheum.170548
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center